{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:51:34Z","timestamp":1769507494973,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vhri.2022.11.002","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T22:44:05Z","timestamp":1673995445000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country"],"prefix":"10.1016","volume":"35","author":[{"given":"Jefferson Antonio","family":"Buend\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Hern\u00e1ndez-Sarmiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Enrique","family":"Rojas Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib1","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2016.01.004","article-title":"Preterm neonatal morbidity and mortality by gestational age: contemporary cohort","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vhri.2022.11.002_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.rmed.2017.10.014","article-title":"Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology","volume":"132","author":"Kalikkot Thekkeveedu","year":"2017","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.vhri.2022.11.002_bib4","first-page":"CD001149","article-title":"Synthetic surfactant for respiratory distress syndrome in preterm infants","volume":"1998","author":"Soll","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.vhri.2022.11.002_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/adc.49.9.743-a","article-title":"A\u00a0simple device for applying both CNP and CPAP in newborn infants suffering from respiratory distress syndrome","volume":"49","author":"Srikasibhandha","year":"1974","journal-title":"Arch Dis Child"},{"issue":"24","key":"10.1016\/j.vhri.2022.11.002_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM197106172842401","article-title":"Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure","volume":"284","author":"Gregory","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.vhri.2022.11.002_bib8","first-page":"CD001243","article-title":"Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants","volume":"10","author":"Subramaniam","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vhri.2022.11.002_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.vhri.2013.10.001","article-title":"Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source","volume":"2","author":"Antonio Buend\u00eda","year":"2013","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/02770903.2020.1830412","article-title":"Cost-utility of use of sputum eosinophil counts to guide management in children with asthma","volume":"59","author":"Buend\u00eda","year":"2022","journal-title":"J Asthma"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1186\/s12913-020-05814-1","article-title":"The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis","volume":"20","author":"Buend\u00eda","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.vhri.2022.11.002_bib12","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/ppul.25024","article-title":"The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children","volume":"55","author":"Buendia","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.vhri.2022.11.002_bib13","first-page":"406","article-title":"[Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source]","volume":"36","author":"Buend\u00eda","year":"2016","journal-title":"Biomedica"},{"issue":"10","key":"10.1016\/j.vhri.2022.11.002_bib14","first-page":"CD002271","article-title":"Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants","volume":"10","author":"Ho","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.vhri.2022.11.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235031","article-title":"Treatment outcomes\u00a0of Pumani bubble-CPAP versus oxygen therapy among preterm babies presenting with respiratory distress at a tertiary hospital in Tanzania-Randomised trial","volume":"15","author":"Mwatha","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vhri.2022.11.002_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/heapol\/czab146","article-title":"Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia","volume":"37","author":"Espinosa","year":"2022","journal-title":"Health Policy Plan"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14737167.1.1.37","article-title":"Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin","volume":"1","author":"Craig","year":"2001","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.vhri.2022.11.002_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected\u00a0value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach","volume":"34","author":"Strong","year":"2014","journal-title":"Med Decis Making"},{"issue":"12","key":"10.1016\/j.vhri.2022.11.002_bib24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s40273-017-0562-9","article-title":"The HTA Risk Analysis Chart: Visualising the need for and potential value of managed entry agreements in health technology assessment","volume":"35","author":"Grimm","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.vhri.2022.11.002_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1099-1050(199906)8:4<323::AID-HEC431>3.0.CO;2-0","article-title":"Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis","volume":"8","author":"Lord","year":"1999","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.vhri.2022.11.002_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.22517\/25395203.22091","article-title":"El parto pret\u00e9rmino desde los registros del nacido vivo en Colombia, per\u00edodo 2008 \u2013 2017","volume":"26","author":"Ger\u00f3nimo Ortega","year":"2020","journal-title":"Revista M\u00e9dica De Risaralda"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s41669-020-00218-7","article-title":"Costs of respiratory syncytial virus hospitalizations in Colombia","volume":"5","author":"Buend\u00eda","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12962-021-00287-3","article-title":"Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma","volume":"19","author":"Buend\u00eda","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"issue":"2","key":"10.1016\/j.vhri.2022.11.002_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14737167.2021.1945445","article-title":"Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia","volume":"22","author":"Jefferson Antonio","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"10.1016\/j.vhri.2022.11.002_bib30","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/pai.13590","article-title":"Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years","volume":"32","author":"Buend\u00eda","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"10","key":"10.1016\/j.vhri.2022.11.002_bib31","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1080\/02770903.2021.1984527","article-title":"Cost\u2011effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma","volume":"59","author":"Buendia","year":"2022","journal-title":"J Asthma"},{"issue":"10","key":"10.1016\/j.vhri.2022.11.002_bib32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1080\/02770903.2021.1980586","article-title":"Cost-utility of azithromycin in patients with severe asthma","volume":"59","author":"Buend\u00eda","year":"2022","journal-title":"J Asthma"},{"issue":"12","key":"10.1016\/j.vhri.2022.11.002_bib33","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1002\/ppul.25645","article-title":"Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma","volume":"56","author":"Buend\u00eda","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.vhri.2022.11.002_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.24953\/turkjped.2021.04.015","article-title":"Cost of illness of RSV infection\u00a0in\u00a0a middle-income tropical country","volume":"63","author":"Buend\u00eda","year":"2021","journal-title":"Turk J Pediatr"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13561-021-00339-7","article-title":"The cost-utility of early use of high-flow nasal cannula in bronchiolitis","volume":"11","author":"Buend\u00eda","year":"2021","journal-title":"Health Econ Rev"},{"issue":"9","key":"10.1016\/j.vhri.2022.11.002_bib36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1080\/03007995.2021.1943342","article-title":"Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective","volume":"37","author":"Buendia","year":"2021","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12913-021-06347-x","article-title":"Budget impact analysis of surfactant therapy for bronchiolitis in critically ill infants: the Colombian National Health System perspective","volume":"21","author":"Buend\u00eda","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.vhri.2022.11.002_bib38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14737167.2022.2011217","article-title":"Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia","volume":"22","author":"Antonio Buend\u00eda","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"12","key":"10.1016\/j.vhri.2022.11.002_bib39","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1080\/02770903.2021.2019266","article-title":"SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis","volume":"59","author":"Buend\u00eda","year":"2022","journal-title":"J\u00a0Asthma"},{"issue":"1","key":"10.1016\/j.vhri.2022.11.002_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12890-021-01777-z","article-title":"Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma","volume":"21","author":"Buend\u00eda","year":"2021","journal-title":"BMC Pulm Med"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109922002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:13:55Z","timestamp":1761941635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109922002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"alternative-id":["S2212109922002047"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2022.11.002","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}